Clinical Trial Update: Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating intravenous and oral steroids for multiple sclerosis attacks was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Deltasone (prednisone)
• Solumedrol (methylprednisolone)

Snippet

Sponsor: Fred Lublin | Conditions: Multiple Sclerosis | Phase 3 | Status: TERMINATED | Results posted: 2017-05-18